ロード中...
Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study
BACKGROUND: White matter hyperintensities (WMHs) are commonly seen on in brain imaging and are associated with stroke and cognitive decline. Therefore, they may provide a relevant intermediate outcome in clinical trials. WMH can be measured as a volume or visually on the Fazekas scale. We investigat...
保存先:
| 出版年: | Trials |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5320698/ https://ncbi.nlm.nih.gov/pubmed/28222778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-1825-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|